https://www.ed.ac.uk/news/ai-powered-blood-test-spots-earliest-breast-cancer-signs-0?utm_source=chatgpt.com
A new screening method that combines laser analysis with a type of AI is the first of its kind to identify patients in the earliest stage of breast cancer, a...
ai poweredblood testbreast cancerspotsearliest
https://www.medindia.net/news/fda-approved-new-gene-test-can-help-some-breast-cancer-patients-avoid-chemo-149454-1.htm
MammaPrint and Blueprint test helps oncologists to evaluate the risk and recurrence of breast cancer by analyzing the tumor's genomic profile.
fda approvedgene testbreast cancernewhelp
https://www.ajc.com/news/health-med-fit-science/fda-approves-first-ever-home-breast-cancer-risk-test/6D03WUjLTP3PtVXp0jJ9KO/
This will be the first at-home DNA test for the three BRCA1/BRCA2 gene mutations most common in people of Eastern European descent.
breast cancer riskfda approvedtest
https://www.egyptindependent.com/blood-test-could-predict-breast-cancer-s-return-study/
An experimental blood test may be able to predict whether a woman with breast cancer will suffer a relapse months before new tumors would be detectable on...
blood testbreast cancercouldpredictreturn
https://www.lbc.co.uk/article/breast-cancer-ai-blood-test-help-prevent-5HjcwhJ_2/
A new AI-powered blood test is the first to detect signs of breast cancer in its earliest stages when it is "far more easily treated", scientists have...
ai poweredblood testfirstspotearliest
https://www.jpost.com/health-and-wellness/article-711828
Oncotest's "Breast Oncotype" test has made it possible to assess, after surgical removal of the tumor, if chemo is necessary or not to prevent recurrence of...
breast cancer testnewhelpdeterminechemotherapy
https://breastcancernow.org/about-us/media/press-releases/breast-cancer-now-funds-research-to-develop-blood-test-that-predicts-the-risk-of-secondary-breast-cancer
Researchers are working to develop a blood test which could predict the likelihood of breast cancer spreading to the bone.
blood testresearchdeveloppredictsrisk
https://www.theflowspace.com/physical-health/prevention-longevity/certitude-blood-test-breast-cancer-ceo-3017798/
Jayant Parthasarathy, CEO of Astrin Biosciences, launched Certitude, an early detection tool for breast cancer that relies on a blood test.
story behindnew bloodbreast cancercertitudebased